v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Cash flows from operating activities        
Net loss $ (8,275) $ (426,075)    
Adjustments to reconcile net loss to net cash used in operating activities        
Depreciation 2,200 5,131    
Amortization of intangible assets 1,020 366,390    
Amortization of right-of-use assets 849 1,258    
Share-based compensation expense 4,459 9,201    
Impairment charges 0 15,000 $ 40,000  
Gain on disposal of assets (48,100) 0    
Accretion of discount and amortization of premium on marketable securities, net (295) (1,706)    
Change in the estimated fair value of contingent consideration 0 (18,700)    
Inventory provision 54 7,659    
Deferred income taxes 0 (546)    
Other 225 719    
Changes in assets and liabilities        
Accounts receivable, net 6,098 (4,121)    
Inventory, net (3,206) (2,538)    
Prepaid expenses and other assets (2,288) 3,426    
Accounts payable (4,322) (1,525)    
Accrued expenses 314 311    
Deferred revenue 19 1,332    
Operating lease liabilities 1,425 (1,618)    
Other liabilities 5,132 2,346    
Net cash used in operating activities (44,691) (44,056)    
Cash flows from investing activities        
Proceeds from disposal of assets 50,000 0    
Payment for waiver of milestone obligation (1,900) 0    
Purchases of property and equipment (3,043) (1,389)    
Purchases of intangible assets (5,000) (5,000)    
Purchases of investments (52,448) (61,820)    
Maturities of investments 48,250 113,443    
Net cash provided by investing activities 35,859 45,234    
Cash flows from financing activities        
Proceeds from issuance of common stock from equity plans 1,437 1,959    
Net cash provided by financing activities 1,437 1,959    
Net (decrease) increase in cash, cash equivalents, and restricted cash (7,395) 3,137    
Cash, cash equivalents, and restricted cash at beginning of period 65,259 57,592    
Cash, cash equivalents, and restricted cash at end of period 57,864 60,729 57,592  
Cash and cash equivalents at end of period 56,274 58,507   $ 63,707
Restricted cash at end of period 1,590 2,222    
Cash, cash equivalents, and restricted cash at end of period 57,864 60,729 $ 57,592 $ 65,259
Supplemental disclosure of non-cash investing and financing activities        
Right-of-use asset and lease liability recognized due to lease extension $ 0 $ 29,575